The reality is simpler than the hype: BPC-157 and TB-500 are not FDA-approved drugs Clinics generally cannot lawfully prescribe or administer them for routine patient care Research use only is not a loophole Research distribution is currently the only compliant framework Understanding this protects researchers, providers, and consumers and keeps legitimate science separate from risky shortcuts.
Kramer A, Green J, Pollard J Jr., Tugendreich S
Use with caution in patients with significant renal failure or CHF
lets take it back to the beginning
Therasse P, Vansteenkiste JF, Zielinski M, DePas TM, Atanackovic D, Swquist LV, Vallieres E, Swisher SG , Adams S, Passlick B, Eberhardt WEE, Grunenwald D, Mok T, Boyer M, Katz A, Douillard JY, Debois M, Brichard VG, Altorki NK